# A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ION904

> **NCT04731623** · PHASE1 · COMPLETED · sponsor: **Ionis Pharmaceuticals, Inc.** · enrollment: 40 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** ION904
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04731623
- **Lead sponsor:** Ionis Pharmaceuticals, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-02-26
- **Primary completion:** 2021-08-12
- **Final completion:** 2021-09-11
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2022-08-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04731623

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04731623, "A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ION904". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04731623. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*